Atossa Therapeutics Inc (NASDAQ:ATOS) told investors it ended 2023 with $88.5 million in cash and cash equivalents and no debt as it advanced its...
Related Keywords
, Atossa Therapeutics Inc , Steven Quay ,
vimarsana.com © 2020. All Rights Reserved.